US Stock MarketDetailed Quotes

CLYM Climb Bio

Watchlist
  • 2.600
  • -0.220-7.80%
Close Dec 13 16:00 ET
  • 2.630
  • +0.030+1.15%
Post 16:12 ET
174.78MMarket Cap-1.53P/E (TTM)

Climb Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Climb Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Climb Bio Earnings Reports

  • Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 12 16:42 ET

  • Climb Bio | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:03 ET

  • Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Second Quarter Financial Results

    Aug 14 06:16 ET

  • Eliem Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 06:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 2, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data